JACOBS LEVY EQUITY MANAGEMENT, INC

Position in MGTX — MeiraGTx Holdings plc

CIK 884414 FLORHAM PARK, NJ

Position in MGTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$118,408

-$328,660 QoQ

Shares Held

13,673

-75.7% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $705,898,155 across 85 Biotechnology names. MGTX ranks #82 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	214,160	$165,468,582
2	INCY	Incyte Corp	1,717,978	$161,696,089
3	ALNY	Alnylam Pharmaceuticals, Inc.	212,204	$70,211,937
4	HALO	Halozyme Therapeutics, Inc.	789,429	$51,020,796
5	RARE	Ultragenyx Pharmaceutical Inc.	1,431,071	$29,980,937
6	EXEL	Exelixis, Inc.	425,982	$18,270,367
7	AUPH	Aurinia Pharmaceuticals Inc.	1,097,189	$16,260,340
8	ARVN	Arvinas, Inc.	1,441,521	$15,280,122

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$118,408	13,673	-75.7%	Shares	Sole	2026-05-15
2025-12-31	$447,068	56,235	-27.3%	Shares	Sole	2026-02-13
2023-03-31	$400,137	77,396	-64.1%	Shares	Sole	2023-05-15
2022-12-31	$1,404,962	215,485	+278.2%	Shares	Sole	2023-02-14
2021-03-31	$822,091	56,971	-24.4%	Shares	Sole	2021-05-17
2020-12-31	$1,140,465	75,328	+86.5%	Shares	Sole	2021-02-16
2020-09-30	$534,816	40,394	+101.4%	Shares	Sole	2020-11-16
2020-06-30	$251,113	20,057	—	Shares	Sole	2020-08-17
No filing history on record for this holder in this stock.